medigraphic.com

2002, Number 4

Next >>

Enf Infec Microbiol 2002; 22 (4)

Antiretroviral therapy in pediatrics and perinatal stage: a challenge to be experienced resistance

Palacios GC

Language: Spanish
References: 9
Page: 173-174
PDF size: 50.12 Kb.


Text Extraction

No abstract


REFERENCES

  1. McKinney RE Jr, Maha MA, Connor EM et al. A multicenter trial for oral zidovudine in children with advanced human immunodeficiency virus disease. The protocol 043 Study group. N Engl J Med 1991;324:1018-1025.

  2. Butler KM, Husson RN, Balis FM et al. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991;324:137-144.

  3. Englund JA, Kaker CJ, Raskino C et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS clinical trial group (ACTG) study 152 team. N Engl J Med 1997;336:1704-1712.

  4. McKinney RE Jr, Johnson GM, Stanley K et al. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr 1998;133:500-508.

  5. Mueller BU, Nelson RP, Sleasman J et al. A phase I/II study of protease inhibitor ritonavir in children with human immunodeficiency virus infection. Pediatrics 1998;101:335-343.

  6. Sáez-Llorens X, -Ramilo O. Early experience with protease inhibitors in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1998;17:728-738.

  7. Palacios GC, Palafox VL, Alvarez-Muñoz MT, Vazquez G, Miranda G, Muñoz O, Solorzano F. Response to two consecutive protease inhibitor combination therapy regimens in a cohort of HIV-1-infected children. Scand J Infect Dis 2002;34:41-44.

  8. Lorenzi P, Spicher VM, Laubereau B et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 1998;12:F241-F247.

  9. Mofenson LM. Centers for Disease Control and Prevention, U.S. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 2002;51(RR-18):1-38.




2020     |     www.medigraphic.com